Late effects of adjuvant chemotherapy on cognitive function:a follow-up study in breast cancer patients
Sanne B. Schagen(The Netherlands Cancer Institute), F.S.A.M. van Dam(The Netherlands Cancer Institute), Rob Rosenbrand(The Netherlands Cancer Institute), Martin Müller(The Netherlands Cancer Institute), Sjoerd Rodenhuis(The Netherlands Cancer Institute), Willem Boogerd(The Netherlands Cancer Institute), Dorothy van Rhijn(The Netherlands Cancer Institute)
Cited by 260
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Mutational Activation of the K-<i>ras</i>Oncogene
|New England Journal of Medicine|1987|540